Statistical methods for the analysis of adverse event data in randomised controlled trials: a scoping review and taxonomy

This article examines whether any statistical methods have been specifically developed to analyse prespecified secondary harm outcomes or non-specific emerging adverse events (AEs) in phase II-IV parallel controlled group trials.